跳至主要内容
临床试验/IRCT20210819052230N1
IRCT20210819052230N1招募中2 期

Study of the efficacy of memantine as adjunctive therapy with chemotherapy regimen in metastatic colon cancer: A pilot randomized clinical trial

Oroumia University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • All patients over 18 years of age with metastatic colon cancer

排除标准

  • Severe renal failure
  • Liver failure (more than 5-fold increase in liver enzymes)
  • History of memantine allergy
  • History of seizures
  • Cardiovascular disease
  • Eye diseases
  • Concomitant use of drugs that alter the pH of the urine.

研究者

发起方
Oroumia University of Medical Sciences

相似试验